BiochemistrybioRxivPreprint
Development of nanobodies as theranostic agents against CMY-2-like class C β-lactamases
F. Cawez, P. S. Mercuri, F. M. Yanez…·M. Galleni
This study identifies VHH nanobodies that inhibit CMY-2 class C β-lactamases and develops an ELISA for detecting these enzymes in resistant bacteria.
DOI 10.1101/2022.07.01.498528